Table of Content

1. Key Insights

2. Executive Summary

3. SWOT Analysis for Diabetic Gastroparesis (DGp)

4. Diabetic Gastroparesis Market Overview at a Glance
4.1. Market Share (%) Distribution of Diabetic Gastroparesis in 2017
4.2. Market Share (%) Distribution of Diabetic Gastroparesis in 2030

5. Disease Background and Overview
5.1. Introduction
5.2. Etiology and risk factors
5.3. Signs and Symptoms
5.4. Pathogenesis of Diabetic Gastroparesis
5.5. Diagnosis
5.5.1. Clinical Scoring System
5.5.2. Differential diagnosis of Diabetic Gastroparesis

6. Epidemiology and Patient Population
6.1. Key Findings
6.2. 7MM Total Prevalent Patient Population of Diabetic Gastroparesis

7. Country Wise-Epidemiology of Diabetic Gastroparesis
7.1. The United States
7.1.1. Assumptions and Rationale
7.1.2. Total Prevalent Cases of Diabetic Gastroparesis in the United States
7.1.3. Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in the United States
7.1.4. Prevalence of Diabetic Gastroparesis based on Gender in the United States
7.1.5. Prevalence of Symptoms associated with DGp in the United States
7.2. EU5
7.2.1. Assumptions and Rationale
7.3. Germany
7.3.1. Total Prevalent Cases of Diabetic Gastroparesis in Germany
7.3.2. Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Germany
7.3.3. Prevalence of Diabetic Gastroparesis based on Gender in Germany
7.3.4. Prevalence of Symptoms associated with DGp in Germany
7.4. France
7.4.1. Total Prevalent Cases of Diabetic Gastroparesis in France
7.4.2. Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in France
7.4.3. Prevalence of Diabetic Gastroparesis based on Gender in France
7.4.4. Prevalence of Symptoms associated with DGp in France
7.5. Italy
7.5.1. Total Prevalent Cases of Diabetic Gastroparesis in Italy
7.5.2. Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Italy
7.5.3. Prevalence of Diabetic Gastroparesis based on Gender in Italy
7.5.4. Prevalence of Symptoms associated with DGp in Italy
7.6. Spain
7.6.1. Total Prevalent Cases of Diabetic Gastroparesis in Spain
7.6.2. Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Spain
7.6.3. Prevalence of Diabetic Gastroparesis based on Gender in Spain
7.6.4. Prevalence of Symptoms associated with DGp in Spain
7.7. The United Kingdom
7.7.1. Total Prevalent Cases of Diabetic Gastroparesis in the UK
7.7.2. Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in the UK
7.7.3. Prevalence of Diabetic Gastroparesis based on Gender in the UK
7.7.4. Prevalence of Symptoms associated with DGp in the UK
7.8. Japan
7.8.1. Assumptions and Rationale
7.8.2. Total Prevalent Cases of Diabetic Gastroparesis in Japan
7.8.3. Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Japan
7.8.4. Prevalence of Diabetic Gastroparesis based on Gender in Japan
7.8.5. Prevalence of Symptoms associated with DGp in Japan

8. Treatment and Management of Diabetic Gastroparesis
8.1. Consensus guidelines for the clinical management of diabetic gastroparesis
8.2. Algorithm for the management of diabetic gastroparesis
8.3. Patient Journey for Diabetic Gastroparesis

9. Appendix
9.1. Bibliography
9.2. Report Methodology


11. Disclaimer

 



List of Figures


Figure 1: SWOT Analysis
Figure 2: Glucose and gastric emptying: bidirectional relationship
Figure 3: Pathophysiology of diabetic gastroparesis
Figure 4: Diagnosis algorithm for Diabetic Gastroparesis
Figure 5: Prevalent Patient Population of Diabetic Gastroparesis in 7MM (2017-2030)
Figure 6: Total Prevalent Cases of Diabetic Gastroparesis in the United States (2017-2030)
Figure 7: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in the US (2017-2030)
Figure 8: Prevalence of Diabetic Gastroparesis based on Gender in the United States (2017-2030)
Figure 9: Prevalence of Symptoms associated with DGp in the United States (2017-2030)
Figure 10: Total Prevalent Cases of Diabetic Gastroparesis in the Germany (2017-2030)
Figure 11: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Germany (2017-2030)
Figure 12: Prevalence of Diabetic Gastroparesis based on Gender in Germany (2017-2030)
Figure 13: Prevalence of Symptoms associated with DGp in Germany (2017-2030)
Figure 14: Total Prevalent Cases of Diabetic Gastroparesis in France (2017-2030)
Figure 15: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in France (2017-2030)
Figure 16: Prevalence of Diabetic Gastroparesis based on Gender in France (2017-2030)
Figure 17: Prevalence of Symptoms associated with DGp in France (2017-2030)
Figure 18: Total Prevalent Cases of Diabetic Gastroparesis in Italy (2017-2030)
Figure 19: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Italy (2017-2030)
Figure 20: Prevalence of Diabetic Gastroparesis based on Gender in Italy (2017-2030)
Figure 21: Prevalence of Symptoms associated with DGp in Italy (2017-2030)
Figure 22: Total Prevalent Cases of Diabetic Gastroparesis in Spain (2017-2030)
Figure 23: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Spain (2017-2030)
Figure 24: Prevalence of Diabetic Gastroparesis based on Gender in Spain (2017-2030)
Figure 25: Prevalence of Symptoms associated with DGp in Spain (2017-2030)
Figure 26: Total Prevalent Cases of Diabetic Gastroparesis in the UK (2017-2030)
Figure 27: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in the UK (2017-2030)
Figure 28: Prevalence of Diabetic Gastroparesis based on Gender in the UK (2017-2030)
Figure 29: Prevalence of Symptoms associated with DGp in the UK (2017-2030)
Figure 30: Total Prevalent Cases of Diabetic Gastroparesis in Japan (2017-2030)
Figure 31: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Japan (2017-2030)
Figure 32: Prevalence of Diabetic Gastroparesis based on Gender in Japan (2017-2030)
Figure 33: Prevalence of Symptoms associated with DGp in Japan (2017-2030)
Figure 34: Suggested therapeutic options for gastroparesis
Figure 35: Algorithm for the management of diabetic gastroparesis.
Figure 36: Patient Journey for DG
Figure 37: Unmet Needs of Diabetic Gastroparesis

 

List of Tables


Table 1: Prevalent Patient Population of Diabetic Gastroparesis in 7MM (2017-2030)
Table 2: Total Prevalent Cases of Diabetic Gastroparesis in the United States (2017-2030)
Table 3: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in the US (2017-2030)
Table 4: Prevalence of Diabetic Gastroparesis based on Gender in the United States (2017-2030)
Table 5: Prevalence of Symptoms associated with DGp in the United States (2017-2030)
Table 6: Total Prevalent Cases of Diabetic Gastroparesis in Germany (2017-2030)
Table 7: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Germany (2017-2030)
Table 8: Prevalence of Diabetic Gastroparesis based on Gender in Germany (2017-2030)
Table 9: Prevalence of Symptoms associated with DGp in the Germany (2017-2030)
Table 10: Total Prevalent Cases of Diabetic Gastroparesis in France (2017-2030)
Table 11: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in France (2017-2030)
Table 12: Prevalence of Diabetic Gastroparesis based on Gender in France (2017-2030)
Table 13: Prevalence of Symptoms associated with DGp in France (2017-2030)
Table 14: Total Prevalent Cases of Diabetic Gastroparesis in Italy (2017-2030)
Table 15: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Italy (2017-2030)
Table 16: Prevalence of Diabetic Gastroparesis based on Gender in Italy (2017-2030)
Table 17: Prevalence of Symptoms associated with DGp in Italy (2017-2030)
Table 18: Total Prevalent Cases of Diabetic Gastroparesis in Spain (2017-2030)
Table 19: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Spain (2017-2030)
Table 20: Prevalence of Diabetic Gastroparesis based on Gender in Spain (2017-2030)
Table 21: Prevalence of Symptoms associated with DGp in Spain (2017-2030)
Table 22: Total Prevalent Cases of Diabetic Gastroparesis in the UK (2017-2030)
Table 23: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in the UK (2017-2030)
Table 24: Prevalence of Diabetic Gastroparesis based on Gender in the UK (2017-2030)
Table 25: Prevalence of Symptoms associated with DGp in the UK (2017-2030)
Table 26: Total Prevalent Cases of Diabetic Gastroparesis in Japan (2017-2030)
Table 27: Prevalence of Gastroparesis Associated with Types of Diabetes Mellitus in Japan (2017-2030)
Table 28: Prevalence of Diabetic Gastroparesis based on Gender in Japan (2017-2030)
Table 29: Prevalence of Symptoms associated with DGp in Japan (2017-2030)